Literature DB >> 10381091

Assay of humoral immunity to mumps virus.

P A Pipkin1, M A Afzal, A B Heath, P D Minor.   

Abstract

One hundred randomly chosen sera from blood donors from North London were assayed for antibodies to mumps virus by plaque reduction and microtitre neutralisation assay, haemagglutination inhibition and in-house ELISA. The assay reproducibility was determined, and there was reasonable agreement between antibody levels measured by the two neutralising methods. Neutralising antibody levels measured by either method were low but the strain used in the assay had a large effect on the antibody titres observed. Titres measured by neutralisation assay, HI assay and ELISA did not correlate well. Assessment of immunity to mumps virus remains problematical.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381091     DOI: 10.1016/s0166-0934(99)00019-1

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  11 in total

1.  Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus.

Authors:  J L Backhouse; H F Gidding; P B McIntyre; G L Gilbert
Journal:  Clin Vaccine Immunol       Date:  2006-07

2.  Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.

Authors:  A Tischer; N Andrews; G Kafatos; A Nardone; G Berbers; I Davidkin; Y Aboudy; J Backhouse; C Barbara; K Bartha; B Bruckova; A Duks; A Griskevicius; L Hesketh; K Johansen; L Jones; O Kuersteiner; E Lupulescu; Z Mihneva; M Mrazova; F De Ory; K Prosenc; F Schneider; A Tsakris; M Smelhausova; R Vranckx; M Zarvou; E Miller
Journal:  Epidemiol Infect       Date:  2007-03-30       Impact factor: 2.451

3.  Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method.

Authors:  Donald R Latner; Marcia McGrew; Nobia J Williams; Sun B Sowers; William J Bellini; Carole J Hickman
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

4.  Serological survey of mumps antibodies in adults in the Czech Republic and the need for changes to the vaccination strategy.

Authors:  Jan Smetana; Roman Chlibek; Irena Hanovcova; Renata Sosovickova; Libuse Smetanova; Petra Polcarova; Peter Gal; Petr Dite
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

5.  Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.

Authors:  Jeremy Mauldin; Kathryn Carbone; Henry Hsu; Robert Yolken; Steven Rubin
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

6.  Differential durability of immune responses to measles and mumps following MMR vaccination.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Antonia Thomas; Beth R Larrabee; Steven Rubin; Gregory A Poland
Journal:  Vaccine       Date:  2019-02-20       Impact factor: 3.641

7.  Two-year antibody persistence in children vaccinated at 12-15 months with a measles-mumps-rubella virus vaccine without human serum albumin.

Authors:  Andrea A Berry; Remon Abu-Elyazeed; Clemente Diaz-Perez; Maurice A Mufson; Christopher J Harrison; Michael Leonardi; Jerry D Twiggs; Christopher Peltier; Stanley Grogg; Antonio Carbayo; Steven Shapiro; Michael Povey; Carmen Baccarini; Bruce L Innis; Ouzama Henry
Journal:  Hum Vaccin Immunother       Date:  2017-05-08       Impact factor: 3.452

8.  Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial.

Authors:  Tetsuo Nakayama; Masahiro Eda; Motonori Hirano; Wakako Goto
Journal:  Hum Vaccin Immunother       Date:  2019-04-22       Impact factor: 3.452

9.  A new method for the detection of neutralizing antibodies against mumps virus.

Authors:  Keita Matsubara; Motoko Fujino; Kaoru Takeuchi; Satoshi Iwata; Tetsuo Nakayama
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

10.  Importance of reporting sequence & serological data from mumps outbreaks in unvaccinated populations.

Authors:  Sarah Connaughton
Journal:  Indian J Med Res       Date:  2016-01       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.